| Scholz M, Ackermann M, Emmrich F, et al.
Effectiveness of cytopenia prophylaxis for different filgrastim and pegfilgrastim schedules in a chemotherapy mouse model. [Journal Article]
Biologics 2009.:27-37.
Abstract | Full Citation | | Bustillo I, Kaley K, Saif MW
Rash associated with the use of pegylated filgrastim in a patient with advanced pancreatic cancer. [JOURNAL ARTICLE]
Cutan Ocul Toxicol 2009 Aug 20.
Abstract | Full Citation | Find Related Articles | | Scholz M, Ackermann M, Engel C, et al.
A pharmacokinetic model of filgrastim and pegfilgrastim application in normal mice and those with cyclophosphamide-induced granulocytopaenia. [JOURNAL ARTICLE]
Cell Prolif 2009 Aug 17.
Abstract | Full Citation | Find Related Articles | | Tomillero A, Moral MA
Gateways to clinical trials. [Journal Article]
Methods Find Exp Clin Pharmacol 2009 Jun; 31(5):341-56.
Abstract | Full Citation | Find Related Articles | | Faderl S, Wierda W, O'Brien S, et al.
Fludarabine, cyclophosphamide, mitoxantrone plus rituximab (FCM-R) in frontline CLL <70 Years. [JOURNAL ARTICLE]
Leuk Res 2009 Jul 29.
Abstract | Full Citation | Find Related Articles | | Donadieu J, Beaupain B, Rety-Jacob F, et al.
Respiratory distress and sudden death of a patient with GSDIb chronic neutropenia: possible role of pegfilgrastim. [Letter, Research Support, Non-U.S. Gov't]
Haematologica 2009 Aug; 94(8):1175-7.
Full Citation | Find Related Articles | | Heaney ML, Toy EL, Vekeman F, et al.
Comparison of hospitalization risk and associated costs among patients receiving sargramostim, filgrastim, and pegfilgrastim for chemotherapy-Induced neutropenia. [JOURNAL ARTICLE]
Cancer 2009 Jul 27.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Renwick W, Pettengell R, Green M
Use of filgrastim and pegfilgrastim to support delivery of chemotherapy: twenty years of clinical experience. [Journal Article]
BioDrugs 2009; 23(3):175-86.
Abstract | Full Citation | | Skarlos DV, Timotheadou E, Galani E, et al.
Pegfilgrastim Administered on the Same Day with Dose-Dense Adjuvant Chemotherapy for Breast Cancer Is Associated with a Higher Incidence of Febrile Neutropenia as Compared to Conventional Growth Factor Support: Matched Case-Control Study of the Hellenic Cooperative Oncology Group. [JOURNAL ARTICLE]
Oncology 2009 Jul 21; 77(2):107-112.
Abstract | Full Citation | Find Related Articles | | Beaupain B, Leblanc T, Reman O, et al.
Is pegfilgrastim safe and effective in congenital neutropenia? An analysis of the French Severe Chronic Neutropenia registry. [JOURNAL ARTICLE]
Pediatr Blood Cancer 2009 Jul 17.
Abstract | Full Citation |    |
|
| | Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo
Advertise on this site.
|
